Teams use GenAI at a SaaS product organization to reduce boilerplate work by 65% for junior developers, allowing more time for problem-solving.
Zendesk's study in 2023 showed that GenAI triage reduced agent time per ticket by 21% across B2B customers.
A medtech firm improved a rare condition detection model by creating 500K synthetic EHR-style records using GenAI, achieving a 17% better F1 score on validation.
GenAI excels at drafting responses, summarizing queries, and categorizing sentiments but requires pairing with verification logic, re-ranking prompts, or human review.
GenAI cannot substitute for embedded systems, multi-modal planning, or full agents but can augment them.
Key sectors like finance, healthcare, and defense face hurdles in adopting GenAI, leaning towards self-hosted or specialized models due to governance concerns.
The market is moving towards agentic systems that combine GenAI with memory, planning, and execution.
LangChain, OpenInterpreter, and crewAI are being adopted in mid-size tech companies, signaling potential growth for GenAI technology.
GenAI's effectiveness is maximized when its limitations are well understood.